Ledger.Open graph →
SEC Form D · filed August 4, 2023

Bilayer Therapeutics, Inc

Offering
$1.0M
Sold
$300K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Carlo G. Traverso · Watertown, MADirectorJoshua A. Korzenik · Cambridge, MADirectorRobert A. Langer · Cambridge, MADirectorThomas A. Collet · Cambridge, MAExec · DirectorHuang G. Yen-Chen · Cambridge, MADirectorDavid G. Zhu · Cambridge, MADirectorCarlo G. Traverso · Watertown, MADirectorJoshua A. Korzenik · Cambridge, MADirectorThomas A. Collet · Cambridge, MAExec · DirectorRobert A. Langer · Cambridge, MADirectorHuang G. Yen-Chen · Cambridge, MADirectorDavid G. Zhu · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗